Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
J Alzheimers Dis. 2018;61(1):145-155. doi: 10.3233/JAD-170466.
The anti-aging protein, α-Klotho, may be involved in cognitive decline and has potential as a surrogate marker that reflects dementia. However, the role of α-Klotho in the brain has not been sufficiently investigated.
Here, we investigated the association between α-Klotho and cognitive decline that is associated with cerebral deep white matter lesions (DWMLs).
Two hundred-eighty participants (187 males and 93 females, mean age: 70.8 years old) were evaluated for DWMLs, and the Fazekas scale (Grade) was assessed following brain magnetic resonance imaging. A questionnaire concerning lifestyle and neuropsychological tests was administered, and their associations with the blood α-Klotho level were retrospectively investigated.
The α-Klotho level was 685.1 pg/mL in Grade 0 (68 subjects), 634.1 in G1 (134), 596.0 in G2 (62), and 571.6 in G3 (16), showing that the level significantly decreased with advanced grades. Significant correlations were noted between the α-Klotho level and higher brain function tests including the Mini-Mental State Examination and word fluency tests (p < 0.05). When a 90th percentile value of the level in the G0 group (400 pg/mL) or lower was defined as a low α-Klotho level, the odds ratio of the high-grade G3 group was 2.9 (95% confidence interval: 1.4-7.8) (after correction for age, sex, hypertension, and chronic kidney disease), which was significant.
A reduced blood α-Klotho level was correlated with grading of cerebral DWMLs and was accompanied by cognitive decline as an independent risk factor. The α-Klotho level may serve as a useful clinical index of vascular cognitive impairment.
抗衰老蛋白α-Klotho 可能与认知能力下降有关,并且有可能成为反映痴呆的替代标志物。然而,α-Klotho 在大脑中的作用尚未得到充分研究。
本研究旨在探讨 α-Klotho 与与脑深部白质病变(DWMLs)相关的认知能力下降之间的关系。
对 280 名参与者(187 名男性和 93 名女性,平均年龄:70.8 岁)进行 DWML 评估,并在脑磁共振成像后评估 Fazekas 量表(分级)。进行了关于生活方式和神经心理学测试的问卷调查,并回顾性调查了它们与血液 α-Klotho 水平的相关性。
α-Klotho 水平在分级 0(68 例)为 685.1pg/mL,在 G1(134 例)为 634.1,在 G2(62 例)为 596.0,在 G3(16 例)为 571.6,表明水平随分级增加而显著降低。α-Klotho 水平与较高的大脑功能测试显著相关,包括 Mini-Mental State Examination 和词语流畅性测试(p<0.05)。当将 G0 组中水平的第 90 百分位数(400pg/mL)或更低定义为低α-Klotho 水平时,高分级 G3 组的优势比为 2.9(95%置信区间:1.4-7.8)(校正年龄、性别、高血压和慢性肾脏病后),差异有统计学意义。
血液 α-Klotho 水平降低与脑 DWML 分级相关,并伴有认知能力下降,作为独立的危险因素。α-Klotho 水平可能是血管性认知障碍的有用临床指标。